Dover price target raised to $197 from $187 at Oppenheimer

Oppenheimer raised the firm’s price target on Dover to $197 from $187 and keeps an Outperform rating on the shares following the Q1 results. Dover is well positioned for earnings upside levered by a recovery in biopharma, the analyst tells investors in a research note.